LONDON, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and ...
Read MoreDALLAS, January 25, 2015 /PRNewswire/ -- MarketReportsOnline.com adds Global Biosimilar Market Trends & Opportunities: 2015 Edition research report of 80 pages on the biosimilars industry to the pharmaceuticals intelligence collection of ...
Read MoreSubscribe to our Free Newsletters!